Aldeyra Therapeutics Inc.

18/11/2024 | Press release | Distributed by Public on 18/11/2024 00:33

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement